ArticleObesity surgery2025
Long-Term Weight Loss Outcomes of One Anastomosis Gastric Bypass: Assessment of 1971 Patients with 5-9-Year Follow-Up.
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06829381 (Tailoring One-Anastomosis Gastric Bypass Based on Total Small Bowel Length - A Randomized Controlled Trial), which is not on this map. Cited by 10 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Tailoring One-Anastomosis Gastric Bypass Based on Total Small Bowel Length - A Randomized Controlled Trial
Who cites it
10 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Long-Term Outcomes of One-Anastomosis Gastric Bypass: A Systematic Review of Studies with at Least 10 Years of Follow-Up.Obesity surgery · 2026Pooled it
- OAGB 2025. A systematic review with meta-analysis of indications and results for primary procedures at 5+ years.Updates in surgery · 2025Pooled it
- Long-Term Outcomes up to 10 Years After Indication-Based Conversion to One-Anastomosis Gastric Bypass or Roux-En-Y Gastric Bypass Following Sleeve Gastrectomy.Obesity surgery · 2026Article
- Scoping Review of Reflux after Primary One Anastomosis Gastric Bypass: Navigating the Maze to Enhance the Evidence Base.Obesity surgery · 2026Review
- Type 2 diabetes mellitus remission 10 years after metabolic and bariatric surgery: a multicenter retrospective study in Poland (BARI‑10‑POL).Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2026Article
- Metabolic and Bariatric Surgery Evolution Over the Past Decades (2009-2024): Insights from the Iranian National Obesity Surgery Database (INOSD).Obesity surgery · 2026Article
- [Metabolic/bariatric surgery is effective : What is the evidence regarding hard endpoints and long-term outcomes?]Chirurgie (Heidelberg, Germany) · 2026Review
- The impact of patient's height-adjusted biliopancreatic limb length on short-term outcomes in one-anastomosis gastric bypass.Scientific reports · 2025Article
- Tailored Biliopancreatic Limb Length to 40% of Total Small Bowel Length in One Anastomosis Gastric Bypass (TABLE-40): Protocol of a Prospective Randomized Controlled Trial.Obesity surgery · 2025Article
- Outcomes and Safety of One Anastomosis Gastric Bypass (OAGB): A Three-Year Retrospective Study.Obesity surgery · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhile OAGB shows promise in the short to medium term, its long-term durability, weight trends, blood levels of metabolic factors and nutrients, and potential complications require further exploration through larger, longer-term studies. This study contributes to the growing body of evidence by reporting on the long-term outcomes of patients with severe obesity who underwent OAGB. METHODS AND PATIENTS: A retrospective study on prospectively collected data was conducted on a sample of 1917 patients who underwent OAGB between 2010 and 2019 and had a BMI ≥ 35 kg/m
resultsIn total, 1971 patients were included, with 1474 (74.8%) female predominance. The mean age and BMI before surgery were 40.31 ± 11.21 years (range 18 to 75 years) and 46.68 ± 6.7 kg/m
conclusionThe results of this study indicate that OAGB has acceptable long-term effects on weight loss and the remission or improvement of obesity-related medical conditions.
Indexed as
Identifiers
39674852What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.